These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 28153333)

  • 21. Congenital transmission of Chagas disease: a clinical approach.
    Oliveira I; Torrico F; Muñoz J; Gascon J
    Expert Rev Anti Infect Ther; 2010 Aug; 8(8):945-56. PubMed ID: 20695749
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Real-life 10-year retention rate of first-line anti-TNF drugs for inflammatory arthritides in adult- and juvenile-onset populations: similarities and differences.
    Favalli EG; Pontikaki I; Becciolini A; Biggioggero M; Ughi N; Romano M; Crotti C; Gattinara M; Gerloni V; Marchesoni A; Meroni PL
    Clin Rheumatol; 2017 Aug; 36(8):1747-1755. PubMed ID: 28597133
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Strongyloidiasis presenting as larva currens 38 years after presumed exposure.
    Showler A; Boggild AK
    J Cutan Med Surg; 2012; 16(6):433-5. PubMed ID: 23149200
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Use of a rapid test on umbilical cord blood to screen for Trypanosoma cruzi infection in pregnant women in Argentina, Bolivia, Honduras, and Mexico.
    Sosa-Estani S; Gamboa-León MR; Del Cid-Lemus J; Althabe F; Alger J; Almendares O; Cafferata ML; Chippaux JP; Dumonteil E; Gibbons L; Padilla-Raygoza N; Schneider D; Belizán JM; Buekens P;
    Am J Trop Med Hyg; 2008 Nov; 79(5):755-9. PubMed ID: 18981518
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Subcutaneous ivermectin in disseminated strongyloidiasis: A veterinary preparation authorised for human use].
    Manrique-Rodríguez S; Martín-Rabadán P; Díaz-Cámara M; Fernández-Llamazares CM
    Med Clin (Barc); 2016 Apr; 146(8):376-7. PubMed ID: 26654554
    [No Abstract]   [Full Text] [Related]  

  • 26. Aortitis in a patient with psoriatic arthritis.
    Tufan A; Engin Tezcan M; Kaya A; Mercan R; Oner Y; Ozturk MA
    Mod Rheumatol; 2012 Sep; 22(5):774-7. PubMed ID: 22143340
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Efficacy of ivermectin in the treatment of children parasitized by Strongyloides stercoralis].
    Ordóñez LE; Angulo ES
    Biomedica; 2004 Mar; 24(1):33-41. PubMed ID: 15239599
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Economic impact of biologic utilization patterns in patients with psoriatic arthritis.
    Schwartzman S; Li Y; Zhou H; Palmer JB
    Clin Rheumatol; 2017 Jul; 36(7):1579-1588. PubMed ID: 28474139
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serological study of Trypanosoma cruzi, Strongyloides stercoralis, HIV, human T cell lymphotropic virus (HTLV) and syphilis infections in asymptomatic Latin-American immigrants in Spain.
    Ramos JM; León R; Andreu M; de las Parras ER; Rodríguez-Díaz JC; Esteban Á; Saugar JM; Torrús D
    Trans R Soc Trop Med Hyg; 2015 Jul; 109(7):447-53. PubMed ID: 26065661
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Psoriatic arthritis.
    Durham LE; Taams LS; Kirkham BW
    Br J Hosp Med (Lond); 2016 Jul; 77(7):C102-8. PubMed ID: 27388392
    [No Abstract]   [Full Text] [Related]  

  • 31. [Conclusion of the consensus workshop organized by the "Société de pathologie exotique" about the Chagas disease in non-endemic areas (26 June 2009, Paris, France)].
    Société de pathologie exotique
    Bull Soc Pathol Exot; 2009 Dec; 102(5):342-6. PubMed ID: 20131431
    [No Abstract]   [Full Text] [Related]  

  • 32. From Lemongrass to Ivermectin: Ethnomedical Management of Chagas Disease in Tropical Bolivia.
    Forsyth C
    Med Anthropol; 2018 Apr; 37(3):236-252. PubMed ID: 28759265
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Pulmonary parasitoses. General aspects].
    L'Her P; Vaylet F; Hovette P
    Rev Pneumol Clin; 1998 Dec; 54(6):321-8. PubMed ID: 10100344
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Switching biologics in the treatment of psoriatic arthritis in Japan.
    Yamamoto T; Ohtsuki M; Sano S; Morita A; Igarashi A; Okuyama R; Kawada A;
    J Dermatol; 2019 Mar; 46(3):e113-e114. PubMed ID: 30156313
    [No Abstract]   [Full Text] [Related]  

  • 35. Strongyloides hyperinfection: a treatment dilemma.
    Miller MA; Church LW; Salgado CD
    Am J Med Sci; 2008 Oct; 336(4):358-61. PubMed ID: 18854683
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Acute strongyloidiasis in a traveller returning from South East Asia.
    Kling K; Kuenzli E; Blum J; Neumayr A
    Travel Med Infect Dis; 2016; 14(5):535-536. PubMed ID: 27192701
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Strongyloidiasis: challenges in diagnosis and management in non-endemic Kuwait.
    Hira PR; Al-Ali F; Shweiki HM; Abdella NA; Johny M; Francis I; Iqbal J; Thompson R; Nevar F
    Ann Trop Med Parasitol; 2004 Apr; 98(3):261-70. PubMed ID: 15119971
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Etanercept-induced myositis: do we have to stop it? A surprising outcome.
    Tariq H; Ayesha B; Weidenheim K; Franchin G
    BMJ Case Rep; 2016 Jan; 2016():. PubMed ID: 26759404
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Paradoxical reaction to etanercept: development of pyoderma gangraenosum during therapy of psoriasis arthritis.
    Kowalzick L; Bertolini J; Baumann C; Walther B; Truhm B; Eickenscheidt L
    J Dtsch Dermatol Ges; 2013 May; 11(5):447-9. PubMed ID: 23343137
    [No Abstract]   [Full Text] [Related]  

  • 40. [Disseminated strongyloidiasis].
    Nozais JP; Thellier M; Datry A; Danis M
    Presse Med; 2001 Apr; 30(16):813-8. PubMed ID: 11388155
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.